Medications for Social Anxiety Disorder
Other names:
Phobia, social; Social Phobia
What is Social Anxiety Disorder:
Social anxiety disorder is a condition that causes you to fear social situations. It is also called social phobia. The fear can cause problems with work, school, or other daily activities.
Medications to treat Social Anxiety Disorder
The following list of medications are in some way related to, or
used in the treatment of this condition.
|
Drug name
|
Rx / OTC
|
Preg
|
CSA
|
Alcohol |
Reviews
|
Rating
|
Popularity
|
|
Zoloft
|
Rx
|
C
|
N
|
X
|
170 reviews
|
7.0
|
|
|
Generic name: sertraline systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
Effexor XR
|
Rx
|
C
|
N
|
X
|
11 reviews
|
7.0
|
|
|
Generic name: venlafaxine systemic
Drug class:
serotonin-norepinephrine reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
Luvox CR
|
Rx
|
C
|
N
|
X
|
1 review
|
9.0
|
|
|
Generic name: fluvoxamine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
Paxil
|
Rx
|
D
|
N
|
X
|
51 reviews
|
8.0
|
|
|
Generic name: paroxetine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
AHFS DI Monograph,
Prescribing Information
|
| |
|
sertraline
|
Rx
|
C
|
N
|
X
|
201 reviews
|
7.0
|
|
|
Generic name: sertraline systemic
Brand name:
Zoloft
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
venlafaxine
|
Rx
|
C
|
N
|
X
|
19 reviews
|
6.0
|
|
|
Generic name: venlafaxine systemic
Brand name:
Effexor XR
Drug class:
serotonin-norepinephrine reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
paroxetine
|
Rx
|
D
|
N
|
X
|
61 reviews
|
8.0
|
|
|
Generic name: paroxetine systemic
Brand names:
Paxil,
Paxil CR,
Pexeva
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
risperidone
Off Label
|
Rx
|
C
|
N
|
X
|
4 reviews
|
6.0
|
|
|
Generic name: risperidone systemic
Drug class:
atypical antipsychotics
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
fluvoxamine
|
Rx
|
C
|
N
|
X
|
1 review
|
9.0
|
|
|
Generic name: fluvoxamine systemic
Brand name:
Luvox CR
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
Paxil CR
|
Rx
|
D
|
N
|
X
|
1 review
|
7.0
|
|
|
Generic name: paroxetine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
Pexeva
|
Rx
|
D
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: paroxetine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
atomoxetine
Off Label
|
Rx
|
C
|
N
|
|
2 reviews
|
4.0
|
|
|
Generic name: atomoxetine systemic
Drug class:
CNS stimulants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
Learn more about Social Anxiety Disorder
Legend
| Off Label |
This medication may not be approved by the FDA for the treatment of this condition. |
| Prescription Only / Over the Counter |
| Rx |
Prescription Only |
| OTC |
Over the Counter |
| Rx/OTC |
Prescription or Over the Counter |
| Pregnancy |
| A |
Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B |
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C |
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D |
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X |
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N |
FDA has not classified the drug. |
| Controlled Substances Act Schedule |
| N |
Is not subject to the Controlled Substances Act. |
| 1 |
Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 |
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 |
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 |
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 |
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol |
| X |
Interacts with Alcohol. |
Browse Drugs by Condition
